Pfizer

PFENYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$159.192 B

$27.93 +0.69%

Close of 22 Sept 2026

Revenue

$62.6B

#66 by revenue

Earnings

$7.77B

#60 by earnings

Shares outstanding

5,699,673,589

Latest filing cover page

P/E ratio

20.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#7Abbott LaboratoriesABT$179.4B
#8Novo Nordisk A SNVO$174.5B
#9PfizerPFE$159.2B
#10Vertex PharmaceuticalsVRTX$130.5B
#11Bristol Myers SquibbBMY$127.2B

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of Pfizer, worth $2.96M. Grants and option exercises are excluded.

Albert BourlaChairman & CEO$1.00M
38,000 shares at $26.34 on 12 Aug 2026 · filed 12 Aug 2026
Ronald E. Blaylock$998.8K
39,231 shares at $25.46 on 5 Aug 2026 · filed 5 Aug 2026
Mortimer J. Buckley$960.4K
37,632 shares at $25.52 on 5 Aug 2026 · filed 5 Aug 2026

What if Pfizer were worth as much as…

Open the what-if tool →

Gold $30.2T

$5,304.51

Per share 190× higher

Bitcoin $1.74T

$305.57

Per share 10.9× higher

Nvidia $5.52T

$967.73

Per share 34.6× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for Pfizer are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.